Sumitomo Life Insurance Co. Decreases Holdings in CME Group Inc (NASDAQ:CME)

Sumitomo Life Insurance Co. decreased its position in shares of CME Group Inc (NASDAQ:CME) by 4.4% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 17,006 shares of the financial services provider’s stock after selling 790 shares during the quarter. Sumitomo Life Insurance Co.’s holdings in CME Group were worth $3,301,000 at the end of the most recent quarter.

Several other large investors have also recently made changes to their positions in the company. FMR LLC boosted its stake in shares of CME Group by 5.7% during the 1st quarter. FMR LLC now owns 6,553,654 shares of the financial services provider’s stock worth $1,078,600,000 after acquiring an additional 355,566 shares in the last quarter. Janus Henderson Group PLC boosted its stake in shares of CME Group by 10.7% during the 1st quarter. Janus Henderson Group PLC now owns 6,229,661 shares of the financial services provider’s stock worth $1,025,278,000 after acquiring an additional 603,645 shares in the last quarter. Geode Capital Management LLC raised its position in shares of CME Group by 12.9% during the 4th quarter. Geode Capital Management LLC now owns 4,715,269 shares of the financial services provider’s stock worth $885,776,000 after purchasing an additional 537,917 shares during the last quarter. Northern Trust Corp raised its position in shares of CME Group by 1.0% during the 1st quarter. Northern Trust Corp now owns 4,212,490 shares of the financial services provider’s stock worth $693,291,000 after purchasing an additional 42,753 shares during the last quarter. Finally, Fiera Capital Corp raised its position in shares of CME Group by 7.2% during the 1st quarter. Fiera Capital Corp now owns 2,531,242 shares of the financial services provider’s stock worth $416,592,000 after purchasing an additional 169,830 shares during the last quarter. 84.58% of the stock is currently owned by institutional investors and hedge funds.

CME Group stock traded up $6.83 during trading on Tuesday, reaching $208.71. 781,294 shares of the company’s stock were exchanged, compared to its average volume of 1,258,474. The business’s 50-day simple moving average is $201.04. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.04 and a current ratio of 1.05. CME Group Inc has a 52-week low of $161.05 and a 52-week high of $207.84. The company has a market cap of $73.25 billion, a price-to-earnings ratio of 30.60, a price-to-earnings-growth ratio of 4.58 and a beta of 0.23.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.75 by $0.01. CME Group had a net margin of 39.36% and a return on equity of 9.14%. The firm had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the prior year, the company earned $1.74 EPS. The firm’s revenue was up 20.1% on a year-over-year basis. As a group, research analysts anticipate that CME Group Inc will post 6.66 EPS for the current fiscal year.

In other news, insider Hilda Harris Piell sold 1,132 shares of the stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $188.05, for a total transaction of $212,872.60. Following the transaction, the insider now owns 33,011 shares of the company’s stock, valued at $6,207,718.55. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kathleen M. Cronin sold 4,960 shares of the stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $186.69, for a total transaction of $925,982.40. Following the transaction, the insider now directly owns 49,337 shares in the company, valued at approximately $9,210,724.53. The disclosure for this sale can be found here. Over the last three months, insiders sold 88,873 shares of company stock valued at $17,497,999. 1.20% of the stock is currently owned by corporate insiders.

CME has been the subject of several research reports. Wells Fargo & Co lifted their price objective on CME Group from $176.00 to $200.00 and gave the stock a “market perform” rating in a research report on Wednesday, July 3rd. Bank of America set a $180.00 price objective on CME Group and gave the stock a “hold” rating in a research report on Tuesday, April 9th. Rosenblatt Securities downgraded CME Group from a “neutral” rating to a “sell” rating in a research report on Thursday, April 18th. UBS Group lifted their price objective on CME Group from $190.00 to $194.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 3rd. Finally, BidaskClub downgraded CME Group from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 11th. Three equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and an average price target of $192.14.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Featured Article: Dead Cat Bounce

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.